Listed

MACOM Technology Solutions Holdings, Inc.: Form 10-Q for the period ended Mar 31, 2023

Filed with the SEC on May 4, 2023 and accepted by EDGAR at May 4, 2023, 16:08 ET.

Share

Management's discussion and analysis

As filed, 30,773 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and the notes thereto included elsewhere in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the fiscal year ended September 30, 2022 filed with the United States Securities and Exchange Commission (“SEC”) on November 14, 2022 (the “2022 Annual Report on Form 10-K”).

In this document, the words “Company,” “we,” “our,” “us,” and similar terms refer only to MACOM Technology Solutions Holdings, Inc. and its consolidated subsidiaries, and not any other person or entity.

“MACOM,” “MACOM Technology Solutions,” and related logos are trademarks of MACOM Technology Solutions Holdings, Inc. All other brands and names listed are trademarks of their respective owners.

Cautionary Note Regarding Forward-Looking Statements

This Item 2, “Management's Discussion and Analysis of Financial Condition and Results of Operations” and other sections of this Quarterly Report on Form 10-Q contain “forward-looking statements.” In addition, we may make other written and oral communications from time to time that contain such statements. Forward-looking statements include statements regarding our business outlook, strategic plans and priorities, expectations, anticipated drivers of future revenue growth, our ability to better address certain markets, expand our capabilities and extend our product offerings through the Linearizer Acquisition, our pending acquisition of OMMIC SAS, industry trends, the potential impacts of COVID-19 on our future operations and results, our estimated annual effective tax rate, our plans for use of our cash and cash equivalents and short-term investments, interest rate and foreign currency risks, our ability to meet working capital requirements, estimates and objectives for future operations, our future results of operations and our financial position, including liquidity, and other matters that do not relate strictly to historical facts. Forward-looking statements generally may be identified by terms such as “anticipates,” “believes,” “could,” “continue,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “seeks,” “should,” “targets,” “will,” “would” or similar expressions or variations or the negatives of those terms. These statements are based on management's beliefs and assumptions as of the date of this Quarterly Report on Form 10-Q, based on information currently available to us. Such forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. Important factors that could cause actual results to differ materially from the forward-looking statements include, among others, the risks described in the section entitled “Risk Factors” in this Quarterly Report on Form 10-Q and the 2022 Annual Report on Form 10-K. We caution the reader to carefully consider such factors. Furthermore, such forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.

Overview

We design and manufacture semiconductor products for Telecommunications (“Telecom”), Industrial and Defense (“I&D”) and Data Center industries. Headquartered in Lowell, Massachusetts, with operational facilities throughout North America, Europe and Asia, we design, develop and manufacture differentiated semiconductor products for customers who demand high performance, quality and reliability. We have more than 70 years of application expertise, combined with expertise in analog and mixed signal circuit design, compound semiconductor fabrication (including gallium arsenide, gallium nitride, indium phosphide and specialized silicon), advanced packaging and back-end assembly and test. We offer a broad portfolio of thousands of standard and custom devices, which include integrated circuits (“IC”), multi-chip modules, diodes, amplifiers, switches and switch limiters, passive and active components and complete subsystems, across dozens of product lines serving over 6,000 end customers in three primary markets. Our semiconductor products are electronic components that our customers generally incorporate into larger electronic systems, such as wireless communication systems including basestations, high capacity optical networks, data center applications, radar, medical systems and test and measurement applications. Our primary end markets are: (1) Telecom, which includes carrier infrastructure such as long-haul/metro, 5G and Fiber-to-the-X/passive optical network, among others; (2) I&D, which includes military and commercial radar, radio frequency (“RF”) jammers, electronic countermeasures, communication data links, satellite communications and multi-market applications, which include industrial, medical, test and measurement and scientific applications; and (3) Data Center, which includes intra-Data Center, Data Center Interconnect applications, at 100G, 200G, 400G, 800G and higher speeds, enabled by our broad portfolio of analog ICs and photonic components for high speed optical module customers.

COVID-19 Impact

COVID-19 has spread throughout areas of the world where we operate and resulted in authorities implementing numerous measures to try to contain the virus. As a result of these measures and the spread of COVID-19, we have modified our business practices and may further modify our practices as required, or as we determine appropriate. While these measures, as well as other disruptions, have impacted our operations, the operations of our customers and those of our respective vendors and suppliers, such impacts did not, through the six months ended March 31, 2023, have a material impact on our consolidated operating results. However, the degree to which COVID-19 may impact our business, financial condition, results of operations, liquidity and cash flows will continue to depend on future developments, which remain highly uncertain and cannot be predicted.

For additional information on risk factors that could impact our future results, please refer to the section entitled “Risk Factors” in this Quarterly Report on Form 10-Q and the 2022 Annual Report on Form 10-K.

Description of Our Revenue

Revenue. Our revenue is derived from sales of high-performance RF, microwave, millimeter wave, optical and photonic semiconductor products. We design, integrate, manufacture and package differentiated, semiconductor-based products that we sell to customers through our direct sales organization, our network of independent sales representatives and our distributors.

We believe the primary drivers of our future revenue growth will include:

  • continued growth in the demand for high-performance analog, digital and optical semiconductors in our three primary markets;
  • introducing new products using advanced technologies, added features, higher levels of integration and improved performance;
  • increasing content of our semiconductor solutions in customers’ systems through cross-selling our product lines;
  • leveraging our core strength and leadership position in standard, catalog products that service all of our end applications; and
  • engaging early with our lead customers to develop custom and standard products.

Our core strategy is to develop and innovate high-performance products that address our customers’ most difficult technical challenges in our primary markets: Telecom, I&D and Data Center.

We expect our revenue in the Telecom market to be driven by 5G deployments, with continued upgrades and expansion of communications equipment, and increasing adoption of our high-performance RF, millimeter wave, optical and photonic components.

We expect our revenue in the I&D market to be driven by the expanding product portfolio that we offer which services applications such as test and measurement, satellite communications, civil and military radar, industrial, automotive, scientific and medical applications, further supported by growth in applications for our multi-market catalog products.

We expect our revenue in the Data Center market to be driven by the adoption of cloud-based services and the upgrade of data center architectures to 100G, 200G, 400G and 800G interconnects, which we expect will drive adoption of higher speed optical and photonic components.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based on our condensed consolidated financial statements. The preparation of financial statements, in conformity with GAAP, requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, the reported amounts of revenue and expenses during the reporting period and disclosure of contingent assets and liabilities at the date of the financial statements. By their nature, these estimates and judgments are subject to an inherent degree of uncertainty and could be material if our actual or expected experience were to change unexpectedly. On an ongoing basis, we re-evaluate our estimates and judgments.

We base our estimates and judgments on our historical experience and on other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making the judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates and material effects on our operating results and financial position may result. The accounting policies which our management believes involve the most significant application of judgment or involve complex estimation, are inventories and associated reserves; revenue reserves; goodwill and intangible asset valuation; share-based compensation valuations and income taxes.

Significant management judgment is required in our valuation of goodwill and intangible assets, many of which are based on the creation of forecasts of future operating results that are used in the valuation, including (i) estimation of future cash flows, (ii) estimation of the long-term rate of growth for our business, (iii) estimation of the useful life over which cash flows will occur, (iv) terminal values, if applicable and (v) the determination of our weighted average cost of capital, which helps determine the discount rate. It is possible that these forecasts may change, and our performance projections included in our forecasts of future results may prove to be inaccurate. The value of our goodwill and purchased intangible assets could also be impacted by future adverse changes such as a decline in the valuation of technology company stocks, including the valuation of our common stock, or a significant slowdown in the worldwide economy or in the optical communications equipment or semiconductor industry.

For additional information related to these and other accounting policies refer to Note 2 - Summary of Significant Accounting Policies to our Consolidated Financial Statements included in Item 8 of Part II, “Financial Statements and Supplementary Data,” of the 2022 Annual Report on Form 10-K and Note 1 - Basis of Presentation and Summary of Significant Accounting Policies to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

Results of Operations

The following table sets forth, for the periods indicated, our statements of operations data (in thousands):

Three Months Ended March 31, 2023 April 1, 2022 Six Months Ended March 31, 2023 April 1, 2022
Revenue $169,406 $165,147 $349,510 $324,767
Cost of revenue (1) 66,716 66,158 136,465 131,636
Gross profit 102,690 98,989 213,045 193,131
Operating expenses:
Research and development (1) 35,537 35,455 74,369 70,925
Selling, general and administrative (1) 31,249 30,963 64,189 62,566
Total operating expenses 66,786 66,418 138,558 133,491
Income from operations 35,904 32,571 74,487 59,640
Other income (expense):
Interest income (expense), net 1,634 (1,389) 2,236 (3,082)
Other (expense) income, net (2) (123) (55) (178) 114,853
Total other income (expense), net 1,511 (1,444) 2,058 111,771
Income before income taxes 37,415 31,127 76,545 171,411
Income tax expense 11,660 1,569 21,271 3,026
Net income $25,755 $29,558 $55,274 $168,385

(1) Includes (a) Amortization expense related to intangible assets arising from acquisitions and (b) Share-based compensation expense included in our condensed consolidated statements of operations as set forth below (in thousands):

(a) Intangible amortization expense: Three Months Ended March 31, 2023 April 1, 2022 Six Months Ended March 31, 2023 April 1, 2022
Cost of revenue $988 $1,778 $1,898 $4,283
Selling, general and administrative 5,764 6,276 11,667 13,058
(b) Share-based compensation expense:
Cost of revenue $1,011 $1,073 $2,161 $2,106
Research and development 3,742 3,511 7,974 7,110
Selling, general and administrative 4,707 5,383 10,372 10,700

(2) The six months ended April 1, 2022 includes a gain on the sale of our equity method investment of $118.2 million and net losses of $3.3 million associated with such equity method investment. See Note 4 - Investments to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q for additional information.

The following table sets forth, for the periods indicated, our statements of operations data expressed as a percentage of our revenue:

Three Months Ended March 31, 2023 April 1, 2022 Six Months Ended March 31, 2023 April 1, 2022
Revenue 100.0% 100.0% 100.0% 100.0%
Cost of revenue 39.4 40.1 39.0 40.5
Gross profit 60.6 59.9 61.0 59.5
Operating expenses:
Research and development 21.0 21.5 21.3 21.8
Selling, general and administrative 18.4 18.7 18.4 19.3
Total operating expenses 39.4 40.2 39.6 41.1
Income from operations 21.2 19.7 21.3 18.4
Other income (expense):
Interest income (expense), net 1.0 (0.8) 0.6 (0.9)
Other (expense) income, net (0.1) — (0.1) 35.4
Total other income (expense), net 0.9 (0.9) 0.6 34.4
Income before income taxes 22.1 18.8 21.9 52.8
Income tax expense 6.9 1.0 6.1 0.9
Net income 15.2% 17.9% 15.8% 51.8%

Comparison of the Three and Six Months Ended March 31, 2023 to the Three and Six Months Ended April 1, 2022

Revenue. Our revenue increased by $4.3 million, or 2.6%, to $169.4 million for the three months ended March 31, 2023, from $165.1 million for the three months ended April 1, 2022, and our revenue increased by $24.7 million, or 7.6%, to $349.5 million for the six months ended March 31, 2023, from $324.8 million for the six months ended April 1, 2022. The increase in revenue in the three and six months ended March 31, 2023 is described by end market in the following paragraphs.

Revenue from our primary markets, the percentage of change between the periods presented, and revenue by primary markets expressed as a percentage of total revenue in the periods presented were (in thousands, except percentages):

Three Months Ended March 31, 2023 April 1, 2022 % Change Six Months Ended March 31, 2023 April 1, 2022 % Change
Telecom $53,888 $62,927 (14.4)% $115,337 $118,749 (2.9)%
Industrial & Defense 77,194 67,139 15.0% 154,363 140,285 10.0%
Data Center 38,324 35,081 9.2% 79,810 65,733 21.4%
Total $169,406 $165,147 2.6% $349,510 $324,767 7.6%
Telecom 31.8% 38.1% 33.0% 36.6%
Industrial & Defense 45.6% 40.7% 44.2% 43.2%
Data Center 22.6% 21.2% 22.8% 20.2%
Total 100.0% 100.0% 100.0% 100.0%

In the three months ended March 31, 2023, our Telecom market revenue decreased by $9.0 million, or 14.4%, compared to the three months ended April 1, 2022. In the six months ended March 31, 2023, our Telecom market revenue decreased by $3.4 million, or 2.9%, compared to the six months ended April 1, 2022. The decrease for the three months ended March 31, 2023 was primarily driven by a decrease in sales of products targeted for 5G applications. The decrease for the six months ended March 31, 2023 was primarily driven by a decrease in sales of products targeted for 5G applications and a decrease in sales of legacy backhaul products, partially offset by an increase in sales of RF and microwave products for broadband access and video infrastructure.

In the three months ended March 31, 2023, our I&D market revenue increased by $10.1 million, or 15.0%, compared to the three months ended April 1, 2022. In the six months ended March 31, 2023, our I&D market revenue increased by $14.1 million, or 10.0%, compared to the six months ended April 1, 2022. The increase in the three and six months ended March 31,

2023 was primarily driven by ongoing defense program shipments and expansion of high-performance analog product lines into the I&D market.

In the three months ended March 31, 2023, our Data Center market revenue increased by $3.2 million, or 9.2%, compared to the three months ended April 1, 2022. In the six months ended March 31, 2023, our Data Center market revenue increased by $14.1 million, or 21.4%, compared to the six months ended April 1, 2022. The increase in the three months ended March 31, 2023 was primarily driven by an increase in sales of our legacy connectivity products, which were supply constrained in prior periods, partially offset by a decrease in sales of high-performance analog Data Center products and optical semiconductor products. The increase in the six months ended March 31, 2023 was primarily driven by an increase in sales of our legacy connectivity products, which were supply constrained in prior periods, partially offset by a decrease in sales of optical semiconductor products.

We expect our revenue in the second half of fiscal year 2023 to be negatively impacted by the current macroeconomic conditions, resulting in weaker near-term demand for our products.

Gross profit. Gross margin was 60.6% and 59.9% for the three months ended March 31, 2023 and April 1, 2022, respectively, and 61.0% and 59.5% for the six months ended March 31, 2023 and April 1, 2022, respectively. Gross profit was $102.7 million and $99.0 million for the three months ended March 31, 2023 and April 1, 2022, respectively, and $213.0 million and $193.1 million for the six months ended March 31, 2023 and April 1, 2022, respectively. Gross profit increased for the three months ended March 31, 2023 as compared to the three months ended April 1, 2022 primarily as a result of higher sales, favorable product mix, lower intangible amortization, partially offset by increases in production supplies and employee headcount. Gross profit increased for the six months ended March 31, 2023 as compared to the six months ended April 1, 2022 primarily as a result of higher sales, including $2.0 million of non-recurring license revenue, favorable product mix, lower intangible amortization, partially offset by increases in production supplies, facility-related costs and employee headcount.

Research and development. Research and development expense increased by less than $0.1 million, or 0.2%, to $35.5 million, or 21.0% of our revenue, for the three months ended March 31, 2023, compared to $35.5 million, or 21.5% of our revenue, for the three months ended April 1, 2022. Research and development expense increased by $3.4 million, or 4.9%, to $74.4 million, or 21.3% of our revenue, for the six months ended March 31, 2023, compared to $70.9 million, or 21.8% of our revenue, for the six months ended April 1, 2022. Research and development expense increased in the six months ended March 31, 2023 primarily as a result of an increase in development foundry costs, employee headcount, employee-related costs and share-based compensation expense.

Selling, general and administrative. Selling, general and administrative expense increased by $0.3 million, or 0.9%, to $31.2 million, or 18.4% of our revenue, for the three months ended March 31, 2023, compared to $31.0 million, or 18.7% of our revenue, for the three months ended April 1, 2022. Selling, general and administrative expense increased by $1.6 million, or 2.6%, to $64.2 million, or 18.4% of our revenue, for the six months ended March 31, 2023, compared to $62.6 million, or 19.3% of our revenue, for the six months ended April 1, 2022. Selling, general and administrative expense increased in the three and six months ended March 31, 2023 primarily due to an increase in acquisition-related professional fees, travel expense, variable selling costs, partially offset by a decrease in employee-related costs.

Interest income (expense), net. In the three months ended March 31, 2023, interest income, net was $1.6 million, or 1.0% of our revenue, compared to interest expense, net of $1.4 million, or 0.8% of our revenue, for the three months ended April 1, 2022. In the six months ended March 31, 2023, interest income, net was $2.2 million, or 0.6% of our revenue, compared to interest expense, net of $3.1 million, or 0.9% of our revenue, for the six months ended April 1, 2022. The change for the three and six months ended March 31, 2023 is primarily due to an increase in short-term investments and associated interest income, partially offset by an increase in interest expense on the Term Loans.

Other (expense) income, net. In the three months ended March 31, 2023, other expense, net was $0.1 million, or 0.1% of our revenue, compared to other expense, net of $0.1 million, or 0.03% of our revenue, for the three months ended April 1, 2022. In the six months ended March 31, 2023, other expense, net was $0.2 million, or 0.1% of our revenue, compared to other income, net of $114.9 million, or 35.4% of our revenue, for the six months ended April 1, 2022. The six months ended April 1, 2022 includes a gain on the sale of our equity method investment of $118.2 million and net losses of $3.3 million associated with such equity method investment. See Note 4 - Investments to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q for additional information.

Provision for income taxes. Our income tax expense and effective income tax rates for the periods indicated were (in thousands, except percentages):

Three Months Ended March 31, 2023 April 1, 2022 Six Months Ended March 31, 2023 April 1, 2022
Income tax expense 11,660 1,569 21,271 3,026
Effective income tax rate 31.2% 5.0% 27.8% 1.8%

The difference between the U.S. federal statutory income tax rate of 21% and our effective income tax rate for the three and six months ended March 31, 2023, was primarily driven by tax on GILTI, including changes to Section 174, non-deductible compensation and state income taxes partially offset by income taxed in foreign jurisdictions generally at lower tax rates, and R&D tax credits. The difference between the U.S. federal statutory income tax rate of 21% and our effective income tax rate for the three and six months ended April 1, 2022 was primarily driven by the full valuation allowance against any expense associated with income in the U.S. and income taxed in foreign jurisdictions generally at lower tax rates, where a valuation allowance does not apply. Our estimated annual effective tax rate for the year ending September 29, 2023 is expected to be approximately 30%, adjusted for discrete taxation matters arising during the interim periods.

For additional information refer to Note 14 - Income Taxes to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

Liquidity and Capital Resources

The following table summarizes our cash flow activities (in thousands):

Six Months Ended March 31, 2023 April 1, 2022
Cash and cash equivalents, beginning of period $119,952 $156,537
Net cash provided by operating activities 70,747 76,597
Net cash used in investing activities (24,972) (75,212)
Net cash used in financing activities (29,524) (30,123)
Foreign currency effect on cash 370 (224)
Cash and cash equivalents, end of period $136,573 $127,575

Cash Flow from Operating Activities

Our cash flow from operating activities for the six months ended March 31, 2023 of $70.7 million consisted of a net income of $55.3 million plus adjustments of $63.3 million, to reconcile our net income to cash provided by operating activities, less cash used in operating assets and liabilities of $47.8 million. Adjustments to reconcile our net income to cash provided by operating activities primarily included depreciation and intangible amortization expense of $25.4 million, share-based compensation expense of $20.5 million and deferred income tax expense of $20.2 million. In addition, cash used in operating assets and liabilities was $47.8 million for the six months ended March 31, 2023, primarily driven by a decrease of $17.5 million in accrued and other liabilities, an increase in accounts receivable of $18.3 million, an increase in inventories of $8.2 million.

Our cash flow from operating activities for the six months ended April 1, 2022 of $76.6 million consisted of a net income of $168.4 million, less adjustments of $63.5 million, to reconcile our net income to cash provided by operating activities and cash used in operating assets and liabilities of $28.3 million. Adjustments to reconcile our net income to cash provided by operating activities primarily included a net gain of $114.9 million related to the sale of our equity method investment offset by equity method investment losses, depreciation and intangible amortization expense of $29.1 million and share-based compensation expense of $19.9 million. In addition, cash used in operating assets and liabilities was $28.3 million for the six months ended April 1, 2022, primarily driven by an increase in accounts receivable of $16.0 million, an increase in inventories of $10.7 million and a decrease of $4.9 million in accrued and other liabilities.

Cash Flow from Investing Activities

Our cash flow used in investing activities for the six months ended March 31, 2023 of $25.0 million consisted primarily of cash paid for the Linearizer Acquisition, net of cash acquired of $50.8 million, capital expenditures of $15.6 million and purchases of $228.2 million of short-term investments, offset by proceeds of $261.6 million for the sale and maturity of short-term investments and proceeds from the sale of equipment of $8.0 million.

Our cash flow used in investing activities for the six months ended April 1, 2022 of $75.2 million consisted primarily of purchases of $282.6 million of short-term investments and capital expenditures of $12.2 million, offset by proceeds from the sale of our equity method investment of $127.8 million and proceeds of $91.8 million for the sale and maturity of short-term investments. For additional information on the sale of our equity method investment, see Note 4 - Investments to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

Cash Flow from Financing Activities

During the six months ended March 31, 2023, our cash used in financing activities of $29.5 million was primarily related to $31.3 million of repurchases of common stock associated with employee tax withholdings on vested equity awards, partially offset by $2.3 million of proceeds from employee stock purchases.

During the six months ended April 1, 2022, our cash used in financing activities of $30.1 million was primarily related to $34.8 million of repurchases of stock associated with employee tax withholdings on vested equity awards, partially offset by $5.1 million of proceeds from stock option exercises and employee stock purchases.

Liquidity

As of March 31, 2023, we held $136.6 million of cash and cash equivalents, primarily deposited with financial institutions, as well as $440.7 million of liquid short-term investments. The undistributed earnings of certain foreign subsidiaries are considered indefinitely reinvested for the periods presented and we do not intend to repatriate such earnings. We believe the decision to reinvest these earnings will not have a significant impact on our liquidity. As of March 31, 2023, cash held by our indefinitely reinvested foreign subsidiaries was $11.1 million, which, along with cash generated from foreign operations, is expected to be used in the support of international growth and working capital requirements as well as the repayment of certain intercompany loans.

We plan to use our remaining available cash and cash equivalents and short-term investments for general corporate purposes, including working capital, or for the acquisition of or investment in complementary technologies, design teams, products and businesses. We believe that our cash and cash equivalents, short-term investments and cash generated from operations will be sufficient to meet our working capital requirements for at least the next twelve months. We may need to raise additional capital from time to time through the issuance and sale of equity or debt securities, and there is no assurance that we will be able to do so on favorable terms or at all.

As of March 31, 2023, we had no off-balance sheet arrangements.

For additional information related to our Liquidity and Capital Resources, see Note 9 - Debt to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

Recent Accounting Pronouncements

See Note 1 - Basis of Presentation and Summary of Significant Accounting Policies to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q for information about recent accounting pronouncements.

Market risk

As filed, 3,137 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We are exposed to market risk in the ordinary course of business, which consists primarily of interest rate risk associated with our cash and cash equivalents, short-term investments and our variable rate debt, as well as foreign exchange rate risk.

Interest rate risk. The primary objectives of our investment activity are to preserve principal, provide liquidity and invest excess cash for an average rate of return. To minimize market risk, we maintain our portfolio in cash and diversified investments, which may consist of corporate bonds, bank deposits, money market funds and commercial paper. The interest rates are variable and fluctuate with current market conditions. The risk associated with fluctuating interest rates is limited to this investment portfolio. We believe that a 10% change in interest rates would not have a material impact on our financial position or results of operations. We do not enter into financial instruments for trading or speculative purposes.

Our exposure to interest rate risk also relates to the increase or decrease in the amount of interest expense we must pay on the outstanding debt under the Credit Agreement. The interest rates on our Term Loans are variable interest rates based on our lender’s prime rate or a LIBOR rate, in each case plus an applicable margin, which exposes us to market interest rate risk when we have outstanding borrowings under the Credit Agreement. The UK Financial Conduct Authority announced that they will cease publishing certain tenors of USD LIBOR on June 30, 2023; we expect our interest rate to change to synthetic USD LIBOR during the third quarter of fiscal year 2023. As of March 31, 2023, we had $120.8 million of outstanding borrowings under the Credit Agreement. Assuming our outstanding debt remains constant under the Credit Agreement for an entire year and the applicable annual interest rate increases or decreases by 1%, our annual interest expense would increase or decrease by $1.2 million. The interest rates on our 2026 Convertible Notes are fixed and therefore not subject to interest rate risk.

Foreign currency risk. To date, our international customer agreements have been denominated primarily in U.S. dollars. Accordingly, we have limited exposure to foreign currency exchange rates. The functional currency of a majority of our foreign operations continues to be in U.S. dollars with the remaining operations being local currency. Changes in the value of the U.S. dollar relative to other currencies could make our products more expensive, which could negatively impact demand in certain regions, reduce or delay customer orders, or otherwise negatively affect how customers do business with us. The effects of exchange rate fluctuations on the net assets of the majority of our operations are accounted for as transaction gains or losses. We believe that a change of 10% in such foreign currency exchange rates would not have a material impact on our financial position or results of operations. In the future, we may enter into foreign currency exchange hedging contracts to reduce our exposure to changes in exchange rates.

Controls and procedures

As filed, 1,577 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this Quarterly Report on Form 10-Q, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) were effective as of March 31, 2023.

Changes in Internal Control over Financial Reporting

There were no changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Controls

Our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving the desired control objectives. Our management recognizes that any control system, no matter how well designed and operated, is based upon certain judgments and assumptions and cannot provide absolute assurance that its objectives will be met. Similarly, an evaluation of controls cannot provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected.

Risk factors

As filed, 8,605 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our business involves a high degree of risk. In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2022 Annual Report on Form 10-K, which could materially affect our business, financial condition or future results. As of the date of this Quarterly Report on Form 10-Q, there have been no material changes in any of the risk factors described in our 2022 Annual Report on Form 10-K, except as noted below.

We expect to make future acquisitions and investments, which involve numerous risks.

We routinely evaluate potential acquisitions, investments and strategic alliances involving complementary technologies, design teams, products and companies. We expect to pursue such transactions if appropriate opportunities arise. However, we may not be able to identify suitable transactions in the future or if we do identify such transactions, we may not be able to complete them on commercially acceptable terms or at all and may face intense competition for such opportunities. In the event we pursue a potential transaction, we will face numerous risks, including diverting management’s attention from normal daily operations of our business; difficulties in integrating the financial reporting capabilities and operating systems of any acquired operations to maintain effective internal control over financial reporting and disclosure controls and procedures; potential loss of key personnel of the acquired company as well as their know-how, relationships and expertise; challenges successfully integrating acquired personnel, operations and businesses; failing to realize the anticipated synergies and benefits of an acquisition; maintaining favorable business relationships of acquired operations; generating insufficient revenue from completed transactions to offset expenses associated with our efforts; acquiring material or unknown liabilities associated with any acquired operations; litigation associated with merger and acquisition transactions; and increasing expense associated with amortization or depreciation of intangible and tangible assets we acquire.

Our past acquisitions required significant management time and attention relating to the transactions. Past transactions, whether completed or abandoned by us, have resulted, and in the future may result, in significant time and attention, costs, expenses, liabilities and charges to earnings. The accounting treatment for any future transaction may result in significant amortizable intangible assets which, when amortized, will negatively affect our consolidated results of operations. The accounting treatment may also result in significant goodwill, which, if impaired, will negatively affect our consolidated results of operations. Furthermore, we may incur debt or issue equity securities to pay for transactions. The incurrence of debt could limit our operating flexibility and be detrimental to our profitability, and the issuance of equity securities would be dilutive to our existing stockholders. Any or all of the above factors may differ from the investment community’s expectations in a given quarter, which could negatively affect our stock price. In the event we make future investments, the investments may decline in value, we may lose all or part of our investment.

We may be unable to successfully integrate the businesses and personnel of acquired companies and businesses, and may not realize the anticipated synergies and benefits of such acquisitions.

We may be unable to realize the expected benefits from acquisitions of companies and certain businesses of companies because of integration difficulties or other challenges. The success of our acquisitions will depend, in part, on our ability to realize all or some of the anticipated synergies and other benefits from integrating the acquired businesses with our existing businesses. The integration process may be complex, costly and time-consuming. The potential difficulties we may face in integrating the operations of our acquisitions include, among others: failure to implement our business plans for the combined businesses and consolidation or expansion of production capacity as planned and where applicable; unexpected losses of key employees, customers or suppliers of our acquired companies and businesses; unanticipated issues in conforming our acquired companies’ and businesses’ standards, processes, procedures and controls with our operations; coordinating new product and process development; increasing the scope, geographic diversity and complexity of our operations; diversion of management’s attention from other business concerns; adverse effects on our or our acquired companies’ and businesses’ existing business relationships; unanticipated changes in applicable laws and regulations; operating risks inherent in our acquired companies’ and businesses’ business and operations; unanticipated expenses and liabilities; potential unfamiliarity with our acquired companies and businesses technology, products and markets, which may place us at a competitive disadvantage; and other difficulties in the assimilation of our acquired companies and businesses operations, technologies, products and systems.

Any acquired companies and businesses may have unanticipated or larger than anticipated liabilities for patent and trademark infringement claims, violations of applicable laws, rules and regulations, commercial disputes, taxes and other known and unknown types of liabilities. There may be liabilities that we underestimated or did not discover in the course of performing our due diligence investigation of our acquired companies and businesses. We may have no recourse or limited recourse under the applicable acquisition-related agreement to recover damages relating to the liabilities of our acquired companies and businesses.

We may not be able to maintain or increase the levels of revenue, earnings or operating efficiency that we, and each of our acquired companies and businesses, had historically achieved or might achieve separately. In addition, we may not accomplish the integration smoothly, successfully or within the anticipated costs or timeframe. If we experience difficulties with the integration process or if the business of our acquired companies or businesses deteriorates, the anticipated cost savings, growth opportunities and other synergies of our acquired companies and businesses may not be realized fully or at all, or may take longer to realize than expected. If any of the above risks occur, our business, financial condition, results of operations and cash flows may be materially and adversely impacted, we may fail to meet the expectations of investors or analysts, and our stock price may decline as a result.

Our short-term investment portfolio and certain cash balances could experience a decline in market value or otherwise become illiquid, which could materially and adversely affect our financial results.

As of March 31, 2023, we had approximately $20.6 million in money market funds and $440.7 million in short-term investments, respectively. The debt security investments consisted of commercial paper and corporate bonds. We currently do not use derivative financial instruments to adjust our investment portfolio risk or income profile. These investments, as well as any cash deposited in bank accounts, are subject to general credit, liquidity, market and interest rate risks, which may be exacerbated by unusual events, such as the COVID-19 pandemic, the Eurozone crisis and the U.S. debt ceiling crisis, which affected various sectors of the financial markets and led to global credit and liquidity issues. For example, in March and April 2023, certain US banks were closed and the Federal Deposit Insurance Corporation (FDIC) was appointed as receiver. While we were not directly impacted by these closures and did not have any deposits with these banks, there can be no assurance that our current or future banks will not face similar risks, and that we would be able to recover in full our deposits in the event of similar closures. We regularly maintain cash balances that are not insured or are in excess of the FDIC’s insurance limit. If the global financial markets continue to experience volatility or deteriorate, our investment portfolio and cash balances may be impacted and some or all of our investments may become illiquid or otherwise experience loss which could adversely impact our financial results and position.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-12-31 to 2023-03-31$169.4mus-gaap:Revenues
Revenue6 months2022-10-01 to 2023-03-31$349.5mus-gaap:Revenues
Cost of revenue3 months2022-12-31 to 2023-03-31$66.7mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2022-10-01 to 2023-03-31$136.5mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2022-12-31 to 2023-03-31$102.7mus-gaap:GrossProfit
Gross profit6 months2022-10-01 to 2023-03-31$213.0mus-gaap:GrossProfit
Research and development3 months2022-12-31 to 2023-03-31$35.5mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2022-10-01 to 2023-03-31$74.4mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2022-12-31 to 2023-03-31$31.2mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2022-10-01 to 2023-03-31$64.2mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-12-31 to 2023-03-31$35.9mus-gaap:OperatingIncomeLoss
Operating income6 months2022-10-01 to 2023-03-31$74.5mus-gaap:OperatingIncomeLoss
Income tax3 months2022-12-31 to 2023-03-31$11.7mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2022-10-01 to 2023-03-31$21.3mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-12-31 to 2023-03-31$25.8mus-gaap:NetIncomeLoss
Net income6 months2022-10-01 to 2023-03-31$55.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-12-31 to 2023-03-31$0.36us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2022-10-01 to 2023-03-31$0.77us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-12-31 to 2023-03-31$0.36us-gaap:EarningsPerShareBasic
Basic EPS6 months2022-10-01 to 2023-03-31$0.78us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-12-31 to 2023-03-3171,402,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2022-10-01 to 2023-03-3171,388,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2022-10-01 to 2023-03-31$70.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2022-10-01 to 2023-03-31$15.6mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2022-10-01 to 2023-03-31$31.3mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2023-03-31$136.6mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2023-03-31$848.3mus-gaap:AssetsCurrent
Total assetsAt period end2023-03-31$1.62bnus-gaap:Assets
Current liabilitiesAt period end2023-03-31$91.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-03-31$723.5mus-gaap:Liabilities
Long-term debtAt period end2023-03-31$566.7mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2023-03-31$894.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493594-23-000046. Last ingested by Listed: Nov 14, 2026, 22:08 ET. Listed shows no prices and gives no investment advice.